2011
DOI: 10.1111/j.1600-0463.2011.02730.x
|View full text |Cite
|
Sign up to set email alerts
|

Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended‐spectrum β‐lactamases with focus on CTX‐M in a low‐endemic area in Sweden

Abstract: During the last decade increasing prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae has been detected worldwide, mainly due to dissemination of Escherichia coli and Klebsiella pneumoniae producing CTX-M-type ESBLs. CTX-M-15 is the most widespread CTX-M type, and the predominant type in various countries. Dissemination of ESBL-producing organisms is caused not only by horizontal transfer of plasmids, but also by clonal spread of ESBL-producing strains. In this study, the molecular … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
1
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 29 publications
(33 citation statements)
references
References 33 publications
0
29
1
1
Order By: Relevance
“…The ESBL-producing UPEC was originally isolated from a patient at Örebro University hospital, Sweden. The isolate, designated ESBL019 (previously named ESBL7, Demirel et al, 2015), has previously been characterized and determined to be multidrug resistant (CTX-M-15) and resistant to ceftibuten (MIC 7,680 ng/ml) and belongs to the ST131 clone (Onnberg et al, 2011). ESBL019 was grown in Luria broth (Difco Laboratories, Detroit, MI, USA) overnight on shake at 200 rpm 37°C.…”
Section: Methodsmentioning
confidence: 99%
“…The ESBL-producing UPEC was originally isolated from a patient at Örebro University hospital, Sweden. The isolate, designated ESBL019 (previously named ESBL7, Demirel et al, 2015), has previously been characterized and determined to be multidrug resistant (CTX-M-15) and resistant to ceftibuten (MIC 7,680 ng/ml) and belongs to the ST131 clone (Onnberg et al, 2011). ESBL019 was grown in Luria broth (Difco Laboratories, Detroit, MI, USA) overnight on shake at 200 rpm 37°C.…”
Section: Methodsmentioning
confidence: 99%
“…The identity of the patients was anonymized and after that further analyses of the strains were performed. Antimicrobial susceptibility testing was performed as recommended by the Swedish Reference Group for Antibiotics (http://www.srga.org) and the isolates were genetically characterized for CTX-M, TEM and SHV type by real time PCR and nucleotide sequencing and stored as previously described [16]. MG1655, a well-characterized and non-pathogenic E. coli K-12 strain and CFT073, a UPEC strain isolated from a patient with pyelonephritis, were used as control strains.…”
Section: Methodsmentioning
confidence: 99%
“…Renal epithelial cells were stimulated with three different ESBL isolates (two known cytokine-inducers (ESBL7 and 8) and one non- Table 1 Characteristics of the bacterial isolates included in the study [16,26] inducer (ESBL5)) [16] to evaluate the ability of the isolates to induce cytokines in the presence of three antibiotics (trimetoprim, ceftibuten and ciprofloxacin) representing three different antibiotic classes. The antimicrobial susceptibility testing showed that the isolates were resistant to all of the included antibiotics.…”
Section: Epithelial Cytokine Release Evoked By Esbl-producing E Colimentioning
confidence: 99%
“…Antimicrobial susceptibility testing was performed as recommended by the Swedish Reference Group for Antibiotics (www.srga.org). The included ESBL-producing isolates have been characterized previously [16,26] and were all resistant to trimetoprim, ceftibuten and ciprofloxacin (all from SigmaeAldrich). A reference minimal inhibitory concentration (MIC) of trimetoprim, ceftibuten and ciprofloxacin was determined on two susceptible UPEC isolates.…”
Section: Bacteria Isolates and Susceptibility Testingmentioning
confidence: 99%
See 1 more Smart Citation